Actos, TVM and Zohydro litigation discussed by Andy Birchfield and Leigh O’Dell on Ringler Radio

May 19, 2014 - Beasley Allen attorneys Andy Birchfield and Leigh O'Dell discuss their progress on litigation involving Actos, Transvaginal Mesh and Zohydro. Read More

Federal jury orders drug makers Takeda, Eli Lilly to pay $9 billion for Actos cancer risk

April 8, 2014 - Jurors found Takeda Pharmaceutical Co. and Eli Lilly & Co. liable for a combined $9 billion in punitive damages after finding the drug makers hid cancer risks associated with Actos... Read More

Risperdal side effects include breast development in boys

March 19, 2014 - Risperdal, also known as risperidone, has been linked to a condition known as gynecomastia, characterized by the breast development in boys. Read More

Lawsuits allege heart attack, stroke risk linked to testosterone replacement therapy drugs

February 11, 2014 - Five men are suing Abbott Laboratories and its spinoff company AbbVie Inc., alleging the company hid information that using its testosterone replacement drug AndroGel could increase the... Read More

Study: Testosterone treatment increases risk of heart attack, stroke, death

November 11, 2013 - Testosterone supplements for men have been linked to an increased risk of death, heart attack and stroke, according to study published in the Journal of the American Medical Association... Read More

Beasley Allen attorney Roger Smith discusses antidepressants and life-threatening side effects

October 29, 2013 - Roger Smith visits the Beasley Allen Report to speak about antidepressants and how their widespread usage is exposing thousands to their dangerous, life-threatening side-effects Read More

SSRI antidepressants pose risk to unborn babies

August 28, 2013 - Studies have shown that SSRI use during pregnancy can cause babies to be born with heart defects, defects of the brain and spine, and even lung defects including a life threatening... Read More

Type 2 diabetes drugs may increase risk of pancreatic cancer

August 12, 2013 - A commonly prescribed class of Type 2 diabetes drugs known as incretin mimetics may put users at risk for developing pancreatic cancer, according to new research published in the British... Read More


June 10, 2013 - Recent studies have found a possible link between Lipitor and the risk of developing Type 2 diabetes. Read More

Januvia, Byetta

June 10, 2013 - The FDA has issued several warnings about links between Byetta and Januvia to complications related to pancreatic diseases. Read More

back to top